Firouzjaei et al. [78] performed a randomized clinical trial (RCT) to examine the differences in indices such as weight loss and insulin sensitivity between metformin monotherapy and a combined therapy of metformin and acupuncture in overweight/obese patients with type 2 diabetes. The gene discussed is INS; the disease is type 2 diabetes mellitus.